• November 28, 2020

One-Year Outcomes Data from the OptiMesh® SCOUT (Spineology® Clinical Outcomes Trial) IDE (Investigational Device Exemption) Published in SPINE - Odessa American: Business

e-Edition Subscribe

One-Year Outcomes Data from the OptiMesh® SCOUT (Spineology® Clinical Outcomes Trial) IDE (Investigational Device Exemption) Published in SPINE

Print
Font Size:
Default font size
Larger font size

Posted: Tuesday, November 17, 2020 9:08 am | Updated: 9:32 am, Tue Nov 17, 2020.

ST. PAUL, Minn.--(BUSINESS WIRE)--Nov 17, 2020--

Spineology Inc., an innovator in anatomy-conserving surgery, announces that one-year outcomes data of its Spineology® Clinical Outcomes Trial (SCOUT) has been published online in SPINE, the journal of the North American Spine Society. The article, "One Year Outcomes from a Prospective Multicenter Investigation Device Trial of a Novel Conformal Mesh Interbody Fusion Device,” focuses on trial outcomes of patients treated with the OptiMesh Expandable Interbody Fusion System.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201117005938/en/

The Spineology OptiMesh® Expandable Interbody Fusion System (Photo: Business Wire)

The unique OptiMesh device expands in three dimensions, enabling surgeons to perform interbody fusion procedures through an access smaller than any other fusion procedure. Print publication is anticipated before the end of 2020.

SCOUT was a prospective, multicenter investigational device clinical trial. It demonstrated strong outcomes for the OptiMesh implant at one year, including:

  • Significant reduction in back and leg pain 1
  • Substantial improvement in functional status that occurred early and was sustained through 12 months 1
  • 90 percent “excellent” or “good” patient satisfaction scores 1
  • A 98 percent fusion rate 1
  • An excellent safety record with no serious, device-related, adverse events 1

“We have found this innovative, minimally invasive device to be a safe and effective option for lumbar interbody fusion procedures,” said SCOUT lead investigator John Chi, M.D., M.P.H. Dr. Chi is the Director of Neurosurgical Oncology at Brigham and Women’s Hospital in Boston, Massachusetts, and Associate Professor of Neurosurgery at Harvard Medical School, and the author of the SPINE article. “The outcomes, including high fusion rates, improved function, reduced pain and high satisfaction rates, are very favorable. Additionally, the minimal exposure requirements yielded an exceptional safety profile.”

“Spineology recently received an FDA De Novo Grant for the interbody placement of OptiMesh and is preparing for a Q1 2021 launch,” said John Booth, Spineology’s CEO. “Publication of the SCOUT data is further testimony to the strength of the study. The results demonstrated by OptiMesh along with the experiences of our investigators will help take surgery for low back and leg pain to the next level by providing excellent patient outcomes, enhanced recovery and exceptional efficiency.”

In addition to the SPINE publication, the International Journal of Spine Surgery (IJSS) accepted three manuscripts discussing Spineology’s proprietary mesh technology:

About Spineology Inc.

At Spineology, we are dedicated to transforming spine surgery by providing innovative, anatomy-conserving technologies for surgeons and their patients. Our proprietary mesh technology is used in the OptiMesh and Duo implants, which expand in three dimensions to create large footprints and allow placement of anatomy-conforming interbody fusion devices through very small incisions. This technology preserves spinal anatomy, increases procedural efficiency, and accelerates patient recovery. Learn more at spineology.com.

1 Lu Y, Huang K, Lavoie S, Krag M, Nunley P, Bydon M. Preliminary 24-month Outcomes of a Prospective Investigation of a Novel Mesh Interbody Spacer in Single-Level Fusions. Society for Minimally Invasive Spine Surgery (SMISS) Annual Forum 2019. Las Vegas, NV. 2019 Oct 31 - Nov 2.

View source version on businesswire.com:https://www.businesswire.com/news/home/20201117005938/en/

CONTACT: John J. Booth, Chief Executive Officer

651-256-8511

jbooth@spineology.com

KEYWORD: MINNESOTA UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: SURGERY MEDICAL DEVICES OTHER HEALTH HEALTH CLINICAL TRIALS

SOURCE: Spineology Inc.

Copyright Business Wire 2020.

PUB: 11/17/2020 10:08 AM/DISC: 11/17/2020 10:08 AM

http://www.businesswire.com/news/home/20201117005938/en

© 2020 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Odessa, TX

Current Conditions

Cloudy
42°
Humidity: 89%
Winds: NNE at 9mph
Feels Like: 36°

Your Extended Forecast

Tomorrow

weather
High 53°/Low 32°
Morning showers. Highs in the low 50s and lows in the low 30s.

sunday

weather
High 57°/Low 28°
Sunny. Highs in the upper 50s and lows in the upper 20s.

monday

weather
High 52°/Low 29°
Sunny. Highs in the low 50s and lows in the upper 20s.
Online Features

Pet Central

pets

Having a pet is a lot of responsibility, and we’ll help by giving you lots of tips and tricks! More >>

Fitness

Fitness

Our fitness articles will help teach you how to work out with gym- and home-based exercises. More >>

Crosswords

Crosswords

Enjoy the crosswords challenge in our free daily puzzles, from the harder Sunday crossword to the quicker daily. More >>

Sudoku

Sudoku

Every Sudoku has a unique solution that can be reached logically. Enter numbers into the blank spaces so that each row, column and 3x3 box contains the numbers 1 to 9. More >>




  • ALL-ACCESS: Subscribe to our e-edition and premium website at myoaoa.com.
    You can read your daily newspaper without taking a walk to the driveway.
    Look back at yesterday's newspaper, or issues from months ago with our archive feature.
    Call circulation at 432-337-7314 to sign up today.